Alpha-lipoic acid: A possible pharmacological agent for treating dry eye disease and retinopathy in diabetes

scientific article published on 04 July 2020

Alpha-lipoic acid: A possible pharmacological agent for treating dry eye disease and retinopathy in diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/1440-1681.13373
P698PubMed publication ID32621549

P50authorThekkuttuparambil Ananthanarayanan AjithQ89849638
P2860cites workAntioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistanceQ28392399
Antioxidant-induced modification of INrf2 cysteine 151 and PKC-δ-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance.Q55611195
P921main subjecteye diseaseQ3041498
P577publication date2020-07-04
P1433published inClinical and Experimental Pharmacology and PhysiologyQ5133807
P1476titleAlpha-lipoic acid: A possible pharmacological agent for treating dry eye disease and retinopathy in diabetes

Search more.